WeVote

Bill

Bill

HD 3521

An Act establishing a prescription drug rebate program for seniors

194th Legislature (2025-2026) Introduced by Nick Boldyga

Massachusetts establishes state rebate program to reduce prescription drug costs for seniors by negotiating manufacturer discounts.

0
WeVote Research Nonpartisan
Bill Summary · HD 3521

Legislative bill overview

HD 3521 would establish a state-level prescription drug rebate program specifically designed to reduce out-of-pocket costs for senior citizens in Massachusetts. The bill creates a mechanism for the state to negotiate rebates from pharmaceutical manufacturers and pass savings directly to eligible elderly residents. This represents an attempt to address high medication costs through state intervention rather than relying solely on federal Medicare programs.

Why is this important

Seniors represent a population with high medication needs but often limited fixed incomes, making prescription drug affordability a genuine hardship for many. Massachusetts residents currently pay among the nation's highest drug prices, creating a policy gap between state action and federal Medicare's limited negotiating authority. Such a program could measurably reduce financial strain on elderly households while potentially serving as a model for other states.

Potential points of contention

  • Pharmaceutical industry opposition: Drug manufacturers may challenge the program's legality or resist rebate demands, potentially leading to litigation or reduced drug availability in the state
  • Program funding and cost: Establishing and administering the program requires state revenue; opponents may argue these funds should address other priorities or question whether savings justify administrative overhead
  • Federal-state coordination: The program could conflict with existing Medicare rules, federal rebate structures, or create complications for seniors using both state and federal assistance programs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.